NASDAQ:JBIO - Nasdaq - US0080641071 - Common Stock - Currency: USD
TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
---|---|---|---|---|---|---|---|---|
CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
Net Income | -48.96M | -69.63M | -75.52M | -51.51M | -22.96M | |||
Depreciation Amortization | 258.00K | 282.00K | 96.00K | 70.00K | 20.00K | |||
Change In Working Capital | -8.04M | -11.17M | 9.80M | 7.76M | -6.51M | |||
Other non cash items | 6.84M | 9.32M | 8.85M | 4.57M | 2.06M | |||
OPERATING CASH FLOW | -49.90M | -71.20M | -56.78M | -39.12M | -27.40M | |||
CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
Capital Expenditure | N/A | N/A | -142.00K | -200.00K | -180.00K | |||
Other Investing Activity | 60.05M | 56.03M | 12.02M | 7.12M | -113.25M | |||
INVESTING CASH FLOW | 60.05M | 56.03M | 11.88M | 6.93M | -113.43M | |||
CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
Stock Issued/Repurchased | N/A | 25.73M | 46.23M | 770.00K | 190.46M | |||
Other Financing Activity | N/A | -307.00K | -234.00K | -370.00K | N/A | |||
FINANCING CASH FLOW | N/A | 25.43M | 46.00M | 400.00K | 190.46M | |||
CHANGE IN CASH | 35.10M | 10.26M | 1.09M | -31.79M | 49.63M | |||
FREE CASH FLOW | ||||||||
Operating Cash Flow | -49.90M | -71.20M | -56.78M | -39.12M | -27.40M | |||
Capital Expenditure | N/A | N/A | -142.00K | -200.00K | -180.00K | |||
FREE CASH FLOW | -49.90M | -71.20M | -56.92M | -39.32M | -27.58M |
All data in USD